Anti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to Idelalisib.

Bashash, Davood

Anti-tumor activity of PI3K-δ inhibitor in hematologic malignant cells: Shedding new light on resistance to Idelalisib. [electronic resource] - The international journal of biochemistry & cell biology 04 2017 - 149-158 p. digital

Publication Type: Journal Article

1878-5875

10.1016/j.biocel.2017.02.007 doi


Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Arsenic Trioxide
Arsenicals--pharmacology
Cell Line, Tumor
Cell Survival--drug effects
Drug Resistance, Neoplasm
Drug Synergism
Gene Expression Regulation--drug effects
Humans
Inhibitor of Apoptosis Proteins--genetics
Myeloid Cell Leukemia Sequence 1 Protein--genetics
Oxides--pharmacology
Phosphoinositide-3 Kinase Inhibitors
Protein Kinase Inhibitors--pharmacology
Purines--pharmacology
Quinazolinones--pharmacology
Survivin